CIRCORAN Trademark

Trademark Overview


On Thursday, March 9, 2006, a trademark application was filed for CIRCORAN with the United States Patent and Trademark Office. The USPTO has given the CIRCORAN trademark a serial number of 78833820. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, October 19, 2006. This trademark is owned by Forest Laboratories, Inc.. The CIRCORAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine
circoran

General Information


Serial Number78833820
Word MarkCIRCORAN
Filing DateThursday, March 9, 2006
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, October 19, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, October 19, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameForest Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Party NameForest Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Thursday, October 19, 2006ABANDONMENT - AFTER PUBLICATION
Thursday, October 19, 2006REVIEW OF CORRESPONDENCE COMPLETE
Monday, October 2, 2006TEAS EXPRESS ABANDONMENT RECEIVED
Monday, September 18, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 22, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2006NOTICE OF PUBLICATION
Thursday, June 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 23, 2006ASSIGNED TO LIE
Wednesday, June 21, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2006ASSIGNED TO EXAMINER
Wednesday, March 15, 2006NEW APPLICATION ENTERED IN TRAM